Evidence map›Paper›PMID 39622829›Full record

ArticleNature communications2024

Genetically-stable engineered optogenetic gene switches modulate spatial cell morphogenesis in two- and three-dimensional tissue cultures.

Hannes M Beyer, Sant Kumar, Marius Nieke, Carroll M C Diehl, Kun Tang, Sara Shumka, Cha San Koh, Christian Fleck, Jamie A Davies, Mustafa Khammash and 1 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Remote-controlled genetics: A new frontier in precision therapy.Clinical and translational medicine · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Effects of binding partners on thermal reversion rates of photoswitchable molecules.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hannes M Beyer *Institute of Synthetic Biology, Heinrich-Heine-University Düsseldorf, Universitätsstrasse 1, Düsseldorf, Germany.ORCID 0000-0002-6882-006X
Sant Kumar *Department of Biosystems Science and Engineering (D-BSSE), ETH Zürich, Klingelbergstrasse 48, Basel, Switzerland.ORCID 0000-0002-4056-8501
Marius NiekeInstitute of Synthetic Biology, Heinrich-Heine-University Düsseldorf, Universitätsstrasse 1, Düsseldorf, Germany.ORCID 0009-0006-0291-6954
Carroll M C DiehlInstitute of Synthetic Biology, Heinrich-Heine-University Düsseldorf, Universitätsstrasse 1, Düsseldorf, Germany.ORCID 0009-0001-7136-9900
Kun TangInstitute of Synthetic Biology, Heinrich-Heine-University Düsseldorf, Universitätsstrasse 1, Düsseldorf, Germany.
Sara ShumkaInstitute of Synthetic Biology, Heinrich-Heine-University Düsseldorf, Universitätsstrasse 1, Düsseldorf, Germany.
Cha San KohInstitute of Synthetic Biology, Heinrich-Heine-University Düsseldorf, Universitätsstrasse 1, Düsseldorf, Germany.
Christian FleckFreiburg Center for Data Analysis and Modeling (FDM), University of Freiburg, Ernst-Zermelo-Straße 1, Freiburg im Breisgau, Germany.
Jamie A DaviesDeanery of Biomedical Sciences, University of Edinburgh, Edinburgh, UK.ORCID 0000-0001-6660-4032
Mustafa KhammashDepartment of Biosystems Science and Engineering (D-BSSE), ETH Zürich, Klingelbergstrasse 48, Basel, Switzerland. mustafa.khammash@bsse.ethz.ch.ORCID 0000-0002-4855-9220
Matias D ZurbriggenInstitute of Synthetic Biology, Heinrich-Heine-University Düsseldorf, Universitätsstrasse 1, Düsseldorf, Germany. matias.zurbriggen@uni-duesseldorf.de.ORCID 0000-0002-3523-2907

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) CRC1208 ID 267205415 and CRC1535 ID 458090666Deutsche Forschungsgemeinschaft (German Research Foundation) EXC-2048 Proj no. 390686111Deutsche Forschungsgemeinschaft (German Research Foundation) GRK2466 ID391465903EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 Future and Emerging Technologies (H2020 Excellent Science - Future and Emerging Technologies) Project ID 801041Human Frontier Science Program (HFSP) RGY0063/2017 and RGP 0067/2021
6 · The paper itself

Abstract

Recent advances in tissue engineering have been remarkable, yet the precise control of cellular behavior in 2D and 3D cultures remains challenging. One approach to address this limitation is to genomically engineer optogenetic control of cellular processes into tissues using gene switches that can operate with only a few genomic copies. Here, we implement blue and red light-responsive gene switches to engineer genomically stable two- and three-dimensional mammalian tissue models. Notably, we achieve precise control of cell death and morphogen-directed patterning in 2D and 3D tissues by optogenetically regulating cell necroptosis and synthetic WNT3A signaling at high spatiotemporal resolution. This is accomplished using custom-built patterned LED systems, including digital mirrors and photomasks, as well as laser techniques. These advancements demonstrate the capability of precise spatiotemporal modulation in tissue engineering and open up new avenues for developing programmable 3D tissue and organ models, with significant implications for biomedical research and therapeutic applications.

Indexed as

MorphogenesisOptogeneticsTissue EngineeringAnimalsGenetic EngineeringHumansLightMiceTissue Culture TechniquesWnt3A ProteinWnt3A Protein

Identifiers

PMID39622829
PMCPMC11612184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.